热门资讯> 正文
Candel Therapeutics与Trinity Capital签署1.3亿美元定期贷款安排
2025-10-15 02:56
- Candel Therapeutics (NASDAQ:CADL) announced on Tuesday that it has entered into a five-year, $130M term loan facility with Trinity Capital.
- The facility included four tranches, starting with the first $50M available to draw at closing, followed by the second and third $50M, which were drawn subject to the achievement of certain regulatory, clinical, and operational milestones mentioned in the agreement, and the fourth tranche of $30 million is available at the lender’s discretion.
- The Company plans to use the first tranche, will refinance the prior loan agreement, and provide working capital. Subsequent tranches will be used to fund its general corporate purposes, completion of critical launch readiness, medical affairs and pre-commercialization activities, and potential commercial launch.
More on Candel Therapeutics
- Candel Therapeutics Has A Protracted, But Real, Timeline To Approval Now
- Candel Therapeutics: Potentially The Next Exciting Oncology Story
- Candel Therapeutics: Oncolytic Immunotherapy Showing Broad Efficacy In Tough Tumors
- Erasca, Candle, Xencor drop as BofA downgrades on lack of near-term catalysts
- Seeking Alpha’s Quant Rating on Candel Therapeutics
推荐文章
一周财经日历 |下周重磅事件抢先看：美联储利率决议、科技巨头财报密集来袭
美股机会日报 | 9月CPI低于预期！三大股指期货直线拉升；英特尔盘前大涨超5%
一周IPO | 八马茶业、滴普科技预计下周二上市；传赛力斯最快下周一招股
华盛早报 | 中美将于今起进行经贸磋商；盘后涨超7%！英特尔Q3营收增长2.8%
营收创新高、利润暴跌29%！马斯克的AI豪赌能撑起特斯拉的未来吗？
财报前瞻 | iPhone17热销“带飞”苹果股价！大行绩前集体齐声看涨，Q4季报重点关注什么？
甲骨文两日跌超10%，“超预期宏伟目标”不再“吃香”？
小马智行、文远知行回港上市，迎Robotaxi 的deepseek时刻？
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
